{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:45:28Z","timestamp":1768535128465,"version":"3.49.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","award":["MRCG\/2012\/3"],"award-info":[{"award-number":["MRCG\/2012\/3"]}],"id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","award":["PC112KIN"],"award-info":[{"award-number":["PC112KIN"]}],"id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001593","name":"Irish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001631","name":"University College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.yexmp.2019.104277","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T21:28:46Z","timestamp":1562016526000},"page":"104277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Differential expression of the TP\u03b1 and TP\u03b2 isoforms of the human T Prostanoid receptor during chronic inflammation of the prostate: Role for FOXP1 in the transcriptional regulation of TP\u03b2 during monocyte-macrophage differentiation"],"prefix":"10.1016","volume":"110","author":[{"given":"Eamon P.","family":"Mulvaney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ine G.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah B.","family":"Eivers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Therese","family":"Kinsella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.yexmp.2019.104277_bb0005","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s12094-007-0126-0","article-title":"Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer","volume":"9","author":"Aparicio Gallego","year":"2007","journal-title":"Clin. Transl. Oncol."},{"issue":"10013","key":"10.1016\/j.yexmp.2019.104277_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","article-title":"Prostate cancer","volume":"387","author":"Attard","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02041244","article-title":"The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation","volume":"47","author":"Auwerx","year":"1991","journal-title":"Experientia"},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2019.104277_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fphar.2017.00145","article-title":"Prostate cancer and aspirin use: synopsis of the proposed molecular mechanisms","volume":"8","author":"Bilani","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4049\/jimmunol.158.1.351","article-title":"Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes","volume":"158","author":"Caughey","year":"1997","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.yexmp.2019.104277_bb0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nri1488","article-title":"Forkhead-box transcription factors and their role in the immune system","volume":"4","author":"Coffer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.yexmp.2019.104277_bb0040","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1742-4658.2004.04538.x","article-title":"Characterization of promoter 3 of the human thromboxane A receptor gene. A functional AP-1 and octamer motif are required for basal promoter activity","volume":"272","author":"Coyle","year":"2005","journal-title":"FEBS J."},{"issue":"16","key":"10.1016\/j.yexmp.2019.104277_bb0045","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1046\/j.1432-1033.2002.03098.x","article-title":"Characterization of the 5\u2032 untranslated region of alpha and beta isoforms of the human thromboxane A2 receptor (TP). Differential promoter utilization by the TP isoforms","volume":"269","author":"Coyle","year":"2002","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008668","article-title":"The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages","volume":"5","author":"Daigneault","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.yexmp.2019.104277_bb0055","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.eururo.2006.01.036","article-title":"Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage","volume":"50","author":"Dassesse","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.yexmp.2019.104277_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-642-29423-5_11","article-title":"Thromboxane receptors antagonists and\/or synthase inhibitors","volume":"210","author":"Davi","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.yexmp.2019.104277_bb0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/imm.12451","article-title":"Tissue-resident macrophages: then and now","volume":"144","author":"Davies","year":"2015","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.yexmp.2019.104277_bb0070","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","article-title":"Proliferative inflammatory atrophy of the prostate","volume":"155","author":"De Marzo","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.yexmp.2019.104277_bb0075","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1189\/jlb.0905495","article-title":"Monocyte\/macrophage infiltration in tumors: modulators of angiogenesis","volume":"80","author":"Dirkx","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/bcpt.12156","article-title":"Role of platelets in inflammation and cancer: novel therapeutic strategies","volume":"114","author":"Dovizio","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3\u20134","key":"10.1016\/j.yexmp.2019.104277_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10555-011-9297-9","article-title":"The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis","volume":"30","author":"Ekambaram","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.yexmp.2019.104277_bb0090","first-page":"1","article-title":"The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer","volume":"5","author":"Elkahwaji","year":"2012","journal-title":"Res. Rep. Urol."},{"issue":"6","key":"10.1016\/j.yexmp.2019.104277_bb0095","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.yexmp.2019.104277_bb0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1042\/cs0670653","article-title":"Dexamethasone inhibits the production of thromboxane B2 and leukotriene B4 by human alveolar and peritoneal macrophages in culture","volume":"67","author":"Fuller","year":"1984","journal-title":"Clin. Sci. (Lond.)"},{"issue":"12","key":"10.1016\/j.yexmp.2019.104277_bb0105","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1194\/jlr.M800256-JLR200","article-title":"Regulation of the human thromboxane A2 receptor gene by Sp1, Egr1, NF-E2, GATA-1, and Ets-1 in megakaryocytes","volume":"49","author":"Gannon","year":"2008","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jmb.2009.09.007","article-title":"Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1","volume":"394","author":"Gannon","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.yexmp.2019.104277_bb0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","article-title":"M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide","volume":"15","author":"Genin","year":"2015","journal-title":"BMC Cancer"},{"issue":"1\u20134","key":"10.1016\/j.yexmp.2019.104277_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prostaglandins.2011.08.004","article-title":"Regulation of inflammation in cancer by eicosanoids","volume":"96","author":"Greene","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"5","key":"10.1016\/j.yexmp.2019.104277_bb0125","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126","article-title":"Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo Arm of the prostate cancer prevention trial","volume":"23","author":"Gurel","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"52","key":"10.1016\/j.yexmp.2019.104277_bb0130","doi-asserted-by":"crossref","first-page":"44521","DOI":"10.1074\/jbc.M111.282772","article-title":"Thromboxane receptor signaling is required for fibronectin-induced matrix metalloproteinase 9 production by human and murine macrophages and is attenuated by the Arhgef1 molecule","volume":"286","author":"Hartney","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2019.104277_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2017.03.022","article-title":"Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region","volume":"803","author":"Hennenberg","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.yexmp.2019.104277_bb0140","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI118518","article-title":"Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation","volume":"97","author":"Hirata","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.yexmp.2019.104277_bb0145","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ni1358","article-title":"Foxp1 is an essential transcriptional regulator of B cell development","volume":"7","author":"Hu","year":"2006","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.yexmp.2019.104277_bb0150","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jmcb\/mjt038","article-title":"Thromboxane A2 receptor \u03b1 promotes tumor growth through an autoregulatory feedback pathway","volume":"5","author":"Huang","year":"2013","journal-title":"J. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.yexmp.2019.104277_bb0155","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11255-014-0703-4","article-title":"Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies","volume":"46","author":"Huang","year":"2014","journal-title":"Int. Urol. Nephrol."},{"issue":"7","key":"10.1016\/j.yexmp.2019.104277_bb0160","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ni943","article-title":"Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity","volume":"4","author":"Kabashima","year":"2003","journal-title":"Nat. Immunol."},{"issue":"49","key":"10.1016\/j.yexmp.2019.104277_bb0165","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.yexmp.2019.104277_bb0170","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbagrm.2014.04.010","article-title":"Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers","volume":"1839","author":"Keating","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"Pt 6","key":"10.1016\/j.yexmp.2019.104277_bb0175","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/bst0290641","article-title":"Thromboxane A2 signalling in humans: a 'Tail' of two receptors","volume":"29","author":"Kinsella","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.yexmp.2019.104277_bb0180","series-title":"Transcriptional Regulation of the Human Thromboxane A2 Receptor Gene by Wilms' Tumour (WT)1","first-page":"163","author":"Kinsella","year":"2016"},{"issue":"7","key":"10.1016\/j.yexmp.2019.104277_bb0185","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1517\/14728222.11.7.955","article-title":"FOXP1: a potential therapeutic target in cancer","volume":"11","author":"Koon","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"11","key":"10.1016\/j.yexmp.2019.104277_bb0190","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.035139","article-title":"Cooperation of loss of NKX3.1 and inflammation in prostate cancer initiation","volume":"11","author":"Le Magnen","year":"2018","journal-title":"Dis. Model. Mech."},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0195","article-title":"Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein \u22121 (MCP-1)\/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.yexmp.2019.104277_bb0200","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mc.22020","article-title":"Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells","volume":"53","author":"Li","year":"2014","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.yexmp.2019.104277_bb0205","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"10","key":"10.1016\/j.yexmp.2019.104277_bb0210","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","article-title":"Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression","volume":"177","author":"Martinez","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2019.104277_bb0215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0220","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1038\/s41598-017-07936-9","article-title":"Impaired lymphocyte trafficking in mice deficient in the kinase activity of PKN1","volume":"7","author":"Mashud","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.yexmp.2019.104277_bb0225","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0304-4165(98)00109-3","article-title":"Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) \u03b1 and \u03b2 isoforms","volume":"1425","author":"Miggin","year":"1998","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1\u20132","key":"10.1016\/j.yexmp.2019.104277_bb0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0167-4889(01)00103-3","article-title":"Thromboxane A(2) receptor mediated activation of the mitogen activated protein kinase cascades in human uterine smooth muscle cells","volume":"1539","author":"Miggin","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.yexmp.2019.104277_bb0235","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0026-895X(24)12333-4","article-title":"Regulation of extracellular signal-regulated kinase cascades by alpha- and beta-isoforms of the human thromboxane A(2) receptor","volume":"61","author":"Miggin","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"09","key":"10.1016\/j.yexmp.2019.104277_bb0240","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4236\/jct.2014.59092","article-title":"Inflammation and its role in prostate cancer","volume":"05","author":"Mishra","year":"2014","journal-title":"J. Cancer Ther."},{"issue":"13","key":"10.1016\/j.yexmp.2019.104277_bb0245","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1084\/jem.20140137","article-title":"Thromboxane A2 acts as tonic immunoregulator by preferential disruption of low-avidity CD4+ T cell-dendritic cell interactions","volume":"211","author":"Moalli","year":"2014","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.yexmp.2019.104277_bb0250","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0090-6980(79)80044-1","article-title":"Prostaglandin and thromboxane production by human and Guinea-pig macrophages and leucocytes","volume":"17","author":"Morley","year":"1979","journal-title":"Prostaglandins"},{"issue":"11","key":"10.1016\/j.yexmp.2019.104277_bb0255","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1158\/0008-5472.CAN-07-6560","article-title":"Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis","volume":"68","author":"Moussa","year":"2008","journal-title":"Cancer Res."},{"issue":"45","key":"10.1016\/j.yexmp.2019.104277_bb0260","doi-asserted-by":"crossref","first-page":"73171","DOI":"10.18632\/oncotarget.12256","article-title":"Expression of the TPalpha and TPbeta isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential","volume":"7","author":"Mulvaney","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.yexmp.2019.104277_bb0265","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1464-410x.2001.02193.x","article-title":"Consensus development of a histopathological classification system for chronic prostatic inflammation","volume":"87","author":"Nickel","year":"2001","journal-title":"BJU Int."},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1158\/0008-5472.CAN-07-1018","article-title":"Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase rho","volume":"68","author":"Nie","year":"2008","journal-title":"Cancer Res."},{"issue":"28","key":"10.1016\/j.yexmp.2019.104277_bb0275","doi-asserted-by":"crossref","first-page":"26437","DOI":"10.18632\/oncotarget.4664","article-title":"Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer","volume":"6","author":"O'Sullivan","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.yexmp.2019.104277_bb0280","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.bbadis.2017.09.005","article-title":"Regulated expression of the TPbeta isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: implications for the role of thromboxane in prostate cancer","volume":"1863","author":"O'Sullivan","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.yexmp.2019.104277_bb0285","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbadis.2017.01.011","article-title":"Regulation of protein kinase C-related kinase (PRK) signalling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: implications for thromboxane- and androgen- dependent neoplastic and epigenetic responses in prostate cancer","volume":"1863","author":"O'Sullivan","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.yexmp.2019.104277_bb0290","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","article-title":"Complications of transurethral resection of the prostate (TURP) \u2013 incidence, management, and prevention","volume":"50","author":"Rassweiler","year":"2006","journal-title":"Eur. Urol."},{"issue":"30","key":"10.1016\/j.yexmp.2019.104277_bb0295","doi-asserted-by":"crossref","first-page":"19256","DOI":"10.1016\/S0021-9258(17)32161-0","article-title":"Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor","volume":"269","author":"Raychowdhury","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2019.104277_bb0300","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2741\/3862","article-title":"WT1\/EGR1-mediated control of STIM1 expression and function in cancer cells","volume":"16","author":"Ritchie","year":"2011","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"9826","key":"10.1016\/j.yexmp.2019.104277_bb0305","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.yexmp.2019.104277_bb0310","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1172\/JCI200421100","article-title":"Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1","volume":"114","author":"Shi","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.yexmp.2019.104277_bb0315","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1182\/blood-2008-01-137018","article-title":"Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0320","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.canlet.2015.12.022","article-title":"Regulation of prostate cancer progression by the tumor microenvironment","volume":"380","author":"Shiao","year":"2016","journal-title":"Cancer Lett."},{"issue":"29","key":"10.1016\/j.yexmp.2019.104277_bb0325","doi-asserted-by":"crossref","first-page":"27488","DOI":"10.1074\/jbc.M100636200","article-title":"Characterization of a new subfamily of winged-helix\/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors","volume":"276","author":"Shu","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0330","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2019.104277_bb0335","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ctrv.2016.12.004","article-title":"The immune infiltrate in prostate, bladder and testicular tumors: an old friend for new challenges","volume":"53","author":"Solinas","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.yexmp.2019.104277_bb0340","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fonc.2015.00128","article-title":"Immune infiltration and prostate cancer","volume":"5","author":"Strasner","year":"2015","journal-title":"Front. Oncol."},{"issue":"2\u20133","key":"10.1016\/j.yexmp.2019.104277_bb0345","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejphar.2010.10.052","article-title":"Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms","volume":"650","author":"Strittmatter","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.yexmp.2019.104277_bb0350","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.4049\/jimmunol.171.12.6389","article-title":"Proinflammatory actions of thromboxane receptors to enhance cellular immune responses","volume":"171","author":"Thomas","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0355","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI200113416","article-title":"Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes","volume":"108","author":"Tilley","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.yexmp.2019.104277_bb0360","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/1078-0432.CCR-14-2235","article-title":"Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study","volume":"21","author":"Vidal","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"27","key":"10.1016\/j.yexmp.2019.104277_bb0365","doi-asserted-by":"crossref","first-page":"20412","DOI":"10.1074\/jbc.M907881199","article-title":"The \u03b1, but not the \u03b2, isoform of the human thromboxane A2 receptor is a target for prostacyclin-mediated desensitization","volume":"275","author":"Walsh","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yexmp.2019.104277_bb0370","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.yexmp.2019.104277_bb0375","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pros.20061","article-title":"Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium","volume":"61","author":"Wang","year":"2004","journal-title":"Prostate"},{"issue":"18","key":"10.1016\/j.yexmp.2019.104277_bb0380","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1242\/dev.01287","article-title":"Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation","volume":"131","author":"Wang","year":"2004","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.yexmp.2019.104277_bb0385","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1158\/1078-0432.CCR-04-2405","article-title":"Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer","volume":"11","author":"Wang","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.yexmp.2019.104277_bb0390","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.cellsig.2008.04.006","article-title":"Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide","volume":"20","author":"Wikstrom","year":"2008","journal-title":"Cell. Signal."},{"issue":"10\u221212","key":"10.1016\/j.yexmp.2019.104277_bb0395","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cancergen.2014.09.003","article-title":"Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data","volume":"207","author":"Williams","year":"2014","journal-title":"Cancer Gene Ther."},{"issue":"10","key":"10.1016\/j.yexmp.2019.104277_bb0400","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood-2014-03-559658","article-title":"COX-1-derived thromboxane A2 plays an essential role in early B-cell development via regulation of JAK\/STAT5 signaling in mouse","volume":"124","author":"Yang","year":"2014","journal-title":"Blood"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019302230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019302230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:59:27Z","timestamp":1762145967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480019302230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":80,"alternative-id":["S0014480019302230"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.104277","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential expression of the TP\u03b1 and TP\u03b2 isoforms of the human T Prostanoid receptor during chronic inflammation of the prostate: Role for FOXP1 in the transcriptional regulation of TP\u03b2 during monocyte-macrophage differentiation","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.104277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104277"}}